{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:04:38Z","timestamp":1766023478719,"version":"3.48.0"},"reference-count":51,"publisher":"e-Century Publishing Corporation","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/vxhu6738","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T02:37:41Z","timestamp":1733711861000},"page":"7186-7199","source":"Crossref","is-referenced-by-count":0,"title":["Twelve Shugan Lidan Granules from traditional Chinese medicine can improve liver function in patients with postoperative hepatolithiasis by inhibiting the Hippo signaling pathway"],"prefix":"10.62347","volume":"16","author":[{"given":"Lixiang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF01658357","article-title":"Hepatolithiasis: present status","volume":"8","author":"Nakayama","year":"1984","unstructured":"Nakayama F and Koga A. Hepatolithiasis: present status. World J Surg 1984; 8: 9-14.","journal-title":"World J Surg"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/archsurg.137.2.149","article-title":"Indication and procedure for treatment of hepatolithiasis","volume":"137","author":"Uchiyama","year":"2002","unstructured":"Uchiyama K, Onishi H, Tani M, Kinoshita H, Ueno M and Yamaue H. Indication and procedure for treatment of hepatolithiasis. Arch Surg 2002; 137: 149-153.","journal-title":"Arch Surg"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Shoda J, Tanaka N and Osuga T. Hepatolithiasis--epidemiology and pathogenesis update. Front Biosci 2003; 8: e398-e409.","DOI":"10.2741\/1091"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jamcollsurg.2005.09.022","article-title":"Surgical therapy for hepatolithiasis: a Western experience","volume":"202","author":"Vetrone","year":"2006","unstructured":"Vetrone G, Ercolani G, Grazi GL, Ramacciato G, Ravaioli M, Cescon M, Varotti G, Del Gaudio M, Quintini C and Pinna AD. Surgical therapy for hepatolithiasis: a Western experience. J Am Coll Surg 2006; 202: 306-312.","journal-title":"J Am Coll Surg"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11894-020-00765-3","article-title":"Management of hepatolithiasis: review of the literature","volume":"22","author":"Lorio","year":"2020","unstructured":"Lorio E, Patel P, Rosenkranz L, Patel S and Sayana H. Management of hepatolithiasis: review of the literature. Curr Gastroenterol Rep 2020; 22: 30.","journal-title":"Curr Gastroenterol Rep"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1477-2574.2009.00046.x","article-title":"Surgical management of hepatolithiasis","volume":"11","author":"SV","year":"2009","unstructured":"Sakpal SV, Babel N and Chamberlain RS. Surgical management of hepatolithiasis. HPB (Oxford) 2009; 11: 194-202.","journal-title":"HPB (Oxford)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF01347905","article-title":"Retrospective study","volume":"31","author":"Nakayama","year":"1986","unstructured":"Nakayama F, Soloway RD, Nakama T, Miyazaki K, Ichimiya H, Sheen PC, Ker CG, Ong GB, Choi TK and Boey J. Hepatolithiasis in East Asia. Retrospective study. Dig Dis Sci 1986; 31: 21-26.","journal-title":"Dig Dis Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1440-1746.1991.tb01457.x","article-title":"Hepatolithiasis in East Asia: comparison between Japan and China","volume":"6","author":"Nakayama","year":"1991","unstructured":"Nakayama F, Koga A, Ichimiya H, Todo S, Shen K, Guo RX, Zeng XJ and Zhang ZH. Hepatolithiasis in East Asia: comparison between Japan and China. J Gastroenterol Hepatol 1991; 6: 155-158.","journal-title":"J Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/SLA.0b013e3181b2f374","article-title":"Hepatectomy for bilateral primary hepatolithiasis: a cohort study","volume":"251","author":"Yang","year":"2010","unstructured":"Yang T, Lau WY, Lai EC, Yang LQ, Zhang J, Yang GS, Lu JH and Wu MC. Hepatectomy for bilateral primary hepatolithiasis: a cohort study. Ann Surg 2010; 251: 84-90.","journal-title":"Ann Surg"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"13418","DOI":"10.3748\/wjg.v21.i48.13418","article-title":"Hepatolithiasis and intrahepatic cholangiocarcinoma: a review","volume":"21","author":"Kim","year":"2015","unstructured":"Kim HJ, Kim JS, Joo MK, Lee BJ, Kim JH, Yeon JE, Park JJ, Byun KS and Bak YT. Hepatolithiasis and intrahepatic cholangiocarcinoma: a review. World J Gastroenterol 2015; 21: 13418-13431.","journal-title":"World J Gastroenterol"},{"key":"ref10","unstructured":"Tabata M and Nakayama F. Bacteriology of hepatolithiasis. Prog Clin Biol Res 1984; 152: 163-174."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.surg.2003.09.007","article-title":"Immediate and long-term outcomes of hepatectomy for hepatolithiasis","volume":"135","author":"Chen","year":"2004","unstructured":"Chen DW, Tung-Ping Poon R, Liu CL, Fan ST and Wong J. Immediate and long-term outcomes of hepatectomy for hepatolithiasis. Surgery 2004; 135: 386-393.","journal-title":"Surgery"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00268-006-0441-6","article-title":"Outcomes of hepatectomy for hepatolithiasis","volume":"31","author":"Lee","year":"2007","unstructured":"Lee TY, Chen YL, Chang HC, Chan CP and Kuo SJ. Outcomes of hepatectomy for hepatolithiasis. World J Surg 2007; 31: 479-482.","journal-title":"World J Surg"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1072-7515(99)00109-X","article-title":"Comparison of treatments for hepatolithiasis: hepatic resection versus cholangioscopic lithotomy","volume":"189","author":"Otani","year":"1999","unstructured":"Otani K, Shimizu S, Chijiiwa K, Ogawa T, Morisaki T, Sugitani A, Yamaguchi K and Tanaka M. Comparison of treatments for hepatolithiasis: hepatic resection versus cholangioscopic lithotomy. J Am Coll Surg 1999; 189: 177-182.","journal-title":"J Am Coll Surg"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s00464-014-3669-5","article-title":"Endoscopic or laparoscopic approach for hepatolithiasis in the era of endoscopy in China","volume":"29","author":"Tan","year":"2015","unstructured":"Tan J, Tan Y, Chen F, Zhu Y, Leng J and Dong J. Endoscopic or laparoscopic approach for hepatolithiasis in the era of endoscopy in China. Surg Endosc 2015; 29: 154-162.","journal-title":"Surg Endosc"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/bjs.1800840717","article-title":"Hepatolithiasis associated with cholangiocarcinoma","volume":"84","author":"CH","year":"1997","unstructured":"Su CH, Shyr YM, Lui WY and P&#x2019;Eng FK. Hepatolithiasis associated with cholangiocarcinoma. Br J Surg 1997; 84: 969-973.","journal-title":"Br J Surg"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1002\/1097-0142(19930415)71:8<2461::AID-CNCR2820710806>3.0.CO;2-7","article-title":"A reappraisal of cholangiocarcinoma in patient with hepatolithiasis","volume":"71","author":"Chen","year":"1993","unstructured":"Chen MF, Jan YY, Wang CS, Hwang TL, Jeng LB, Chen SC and Chen TJ. A reappraisal of cholangiocarcinoma in patient with hepatolithiasis. Cancer 1993; 71: 2461-2465.","journal-title":"Cancer"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2536452","DOI":"10.1155\/2019\/2536452","article-title":"Mechanisms underlying the prevention and treatment of cholelithiasis using traditional Chinese medicine","volume":"2019","author":"Chen","year":"2019","unstructured":"Chen Q, Zhang Y, Li S, Chen S, Lin X, Li C and Asakawa T. Mechanisms underlying the prevention and treatment of cholelithiasis using traditional Chinese medicine. Evid Based Complement Alternat Med 2019; 2019: 2536452.","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0039-6060(96)80071-7","article-title":"Surgical treatment of hepatolithiasis: long-term results","volume":"120","author":"Jan","year":"1996","unstructured":"Jan YY, Chen MF, Wang CS, Jeng LB, Hwang TL and Chen SC. Surgical treatment of hepatolithiasis: long-term results. Surgery 1996; 120: 509-514.","journal-title":"Surgery"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12944-020-01334-3","article-title":"The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models","volume":"19","author":"Fan","year":"2020","unstructured":"Fan N, Meng K, Zhang Y, Hu Y, Li D, Gao Q, Wang J, Li Y, Wu S and Cui Y. The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models. Lipids Health Dis 2020; 19: 158.","journal-title":"Lipids Health Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"109128","DOI":"10.1016\/j.biopha.2019.109128","article-title":"Traditional Chinese medicine combined with hepatic targeted drug delivery systems: a new strategy for the treatment of liver diseases","volume":"117","author":"Ma","year":"2019","unstructured":"Ma Z, Zhang B, Fan Y, Wang M, Kebebe D, Li J and Liu Z. Traditional Chinese medicine combined with hepatic targeted drug delivery systems: a new strategy for the treatment of liver diseases. Biomed Pharmacother 2019; 117: 109128.","journal-title":"Biomed Pharmacother"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13020-020-00422-x","article-title":"Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials","volume":"16","author":"Liang","year":"2021","unstructured":"Liang Z, Chen X, Shi J, Hu H, Xue Y and Ung COL. Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials. Chin Med 2021; 16: 9.","journal-title":"Chin Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.gendis.2019.10.016","article-title":"Traditional Chinese medicine as supportive care for the management of liver cancer: past, present, and future","volume":"7","author":"Liao","year":"2019","unstructured":"Liao X, Bu Y and Jia Q. Traditional Chinese medicine as supportive care for the management of liver cancer: past, present, and future. Genes Dis 2019; 7: 370-379.","journal-title":"Genes Dis"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Han W, Li H, Jiang H, Xu H, Lin Y, Chen J, Bi C and Liu Z. Progress in the mechanism of autophagy and traditional Chinese medicine herb involved in alcohol-related liver disease. PeerJ 2023; 11: e15977.","DOI":"10.7717\/peerj.15977"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S2095-4964(14)60039-X","article-title":"Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities","volume":"12","author":"Zhao","year":"2014","unstructured":"Zhao CQ, Zhou Y, Ping J and Xu LM. Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities. J Integr Med 2014; 12: 401-408.","journal-title":"J Integr Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3736\/jcim20080816","article-title":"Effects of different Chinese herbal medicines on biochemical parameters in guinea-pig with pigment gallstones","volume":"6","author":"Zhang","year":"2008","unstructured":"Zhang JZ, Zhang Xl, Liang XQ, Gu HG and Zhu Pt. Effects of different Chinese herbal medicines on biochemical parameters in guinea-pig with pigment gallstones. Zhong Xi Yi Jie He Xue Bao 2008; 6: 856-859.","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"113471","DOI":"10.1016\/j.jep.2020.113471","article-title":"Polysaccharides of vinegar-baked radix bupleuri promote the hepatic targeting effect of oxymatrine by regulating the protein expression of HNF4&#x3B1;, Mrp2, and OCT1","volume":"267","author":"Wu","year":"2021","unstructured":"Wu Y, Liu L, Zhao Y and Zhao R. Polysaccharides of vinegar-baked radix bupleuri promote the hepatic targeting effect of oxymatrine by regulating the protein expression of HNF4&#x3B1;, Mrp2, and OCT1. J Ethnopharmacol 2021; 267: 113471.","journal-title":"J Ethnopharmacol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/s1875-5364(19)30073-1","article-title":"A hepatoprotection study of Radix Bupleuri on acetaminophen-induced liver injury based on CYP450 inhibition","volume":"17","author":"Wang","year":"2019","unstructured":"Wang YX, Du Y, Liu XF, Yang FX, Wu X, Tan L, Lu YH, Zhang JW, Zhou F and Wang GJ. A hepatoprotection study of Radix Bupleuri on acetaminophen-induced liver injury based on CYP450 inhibition. Chin J Nat Med 2019; 17: 517-524.","journal-title":"Chin J Nat Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1638740","DOI":"10.1155\/2022\/1638740","article-title":"A network pharmacology study on the active components and targets of the radix ginseng and radix bupleuri herb pair for treating nonalcoholic fatty liver disease","volume":"2022","author":"Zhang","year":"2022","unstructured":"Zhang Q, Zhang L, Liu K, Shang H, Ruan J, Yu Z, Meng S, Liang F, Wang T, Zhang H, Peng W, Wang Y, Chen J, Xiao T and Wang B. A network pharmacology study on the active components and targets of the radix ginseng and radix bupleuri herb pair for treating nonalcoholic fatty liver disease. Evid Based Complement Alternat Med 2022; 2022: 1638740.","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"102952","DOI":"10.1016\/j.ctim.2023.102952","article-title":"Effects of curcumin\/turmeric supplementation on liver function in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials","volume":"74","author":"Dehzad","year":"2023","unstructured":"Dehzad MJ, Ghalandari H, Amini MR and Askarpour M. Effects of curcumin\/turmeric supplementation on liver function in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. Complement Ther Med 2023; 74: 102952.","journal-title":"Complement Ther Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"5747","DOI":"10.1002\/jsfa.11372","article-title":"Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailability","volume":"101","author":"Abd El-Hack","year":"2021","unstructured":"Abd El-Hack ME, El-Saadony MT, Swelum AA, Arif M, Abo Ghanima MM, Shukry M, Noreldin A, Taha AE and El-Tarabily KA. Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailability. J Sci Food Agric 2021; 101: 5747-5762.","journal-title":"J Sci Food Agric"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"6741213","DOI":"10.1155\/2019\/6741213","article-title":"Turmeric induced liver injury: a report of two cases","volume":"2019","author":"Luber","year":"2019","unstructured":"Luber RP, Rentsch C, Lontos S, Pope JD, Aung AK, Schneider HG, Kemp W, Roberts SK and Majeed A. Turmeric induced liver injury: a report of two cases. Case Reports Hepatol 2019; 2019: 6741213.","journal-title":"Case Reports Hepatol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"8684","DOI":"10.3390\/molecules16108684","article-title":"Hepatoprotective action of Radix Paeoniae Rubra aqueous extract against CCl4-induced hepatic damage","volume":"16","author":"Li","year":"2011","unstructured":"Li R, Guo W, Fu Z, Ding G, Zou Y and Wang Z. Hepatoprotective action of Radix Paeoniae Rubra aqueous extract against CCl4-induced hepatic damage. Molecules 2011; 16: 8684-8694.","journal-title":"Molecules"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3389\/fphar.2020.01054","article-title":"Efficacy, chemical constituents, and pharmacological actions of radix paeoniae rubra and radix paeoniae alba","volume":"11","author":"Tan","year":"2020","unstructured":"Tan YQ, Chen HW, Li J and Wu QJ. Efficacy, chemical constituents, and pharmacological actions of radix paeoniae rubra and radix paeoniae alba. Front Pharmacol 2020; 11: 1054.","journal-title":"Front Pharmacol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/ijms21010265","article-title":"Cryptotanshinone from the salvia miltiorrhiza bunge attenuates ethanol-induced liver injury by activation of AMPK\/SIRT1 and Nrf2 signaling pathways","volume":"21","author":"Nagappan","year":"2019","unstructured":"Nagappan A, Kim JH, Jung DY and Jung MH. Cryptotanshinone from the salvia miltiorrhiza bunge attenuates ethanol-induced liver injury by activation of AMPK\/SIRT1 and Nrf2 signaling pathways. Int J Mol Sci 2019; 21: 265.","journal-title":"Int J Mol Sci"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3390\/cells8050468","article-title":"Role of the hippo pathway in fibrosis and cancer","volume":"8","author":"CL","year":"2019","unstructured":"Kim CL, Choi SH and Mo JS. Role of the hippo pathway in fibrosis and cancer. Cells 2019; 8: 468.","journal-title":"Cells"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/HEP.0000000000000317","article-title":"P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases","volume":"78","author":"Zhang","year":"2023","unstructured":"Zhang J, Lyu Z, Li B, You Z, Cui N, Li Y, Li Y, Huang B, Chen R, Chen Y, Peng Y, Fang J, Wang Q, Miao Q, Tang R, Gershwin ME, Lian M, Xiao X and Ma X. P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases. Hepatology 2023; 78: 10-25.","journal-title":"Hepatology"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.devcel.2019.06.003","article-title":"The hippo signaling pathway in development and disease","volume":"50","author":"Zheng","year":"2019","unstructured":"Zheng Y and Pan D. The hippo signaling pathway in development and disease. Dev Cell 2019; 50: 264-282.","journal-title":"Dev Cell"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"16024","DOI":"10.1038\/nrdp.2016.24","article-title":"Gallstones","volume":"2","author":"Lammert","year":"2016","unstructured":"Lammert F, Gurusamy K, Ko CW, Miquel JF, M&#xE9;ndez-S&#xE1;nchez N, Portincasa P, van Erpecum KJ, van Laarhoven CJ and Wang DQ. Gallstones. Nat Rev Dis Primers 2016; 2: 16024.","journal-title":"Nat Rev Dis Primers"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1007\/s00261-020-02444-3","article-title":"Right posteroinferior bile duct angulation correlates with bile duct stone occurrence in patients with hepatolithiasis","volume":"45","author":"Chen","year":"2020","unstructured":"Chen G, Wu J, Xiao L, Wen Y, Yang T and Wang S. Right posteroinferior bile duct angulation correlates with bile duct stone occurrence in patients with hepatolithiasis. Abdom Radiol (NY) 2020; 45: 3103-3108.","journal-title":"Abdom Radiol (NY)"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.bpg.2006.05.009","article-title":"Gallstone disease: Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic)","volume":"20","author":"Tazuma","year":"2006","unstructured":"Tazuma S. Gallstone disease: Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract Res Clin Gastroenterol 2006; 20: 1075-1083.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/medicina60020340","article-title":"Endoscopic management of difficult biliary stones: an evergreen issue","volume":"60","author":"Manti","year":"2024","unstructured":"Manti M, Shah J, Papaefthymiou A, Facciorusso A, Ramai D, Tziatzios G, Papadopoulos V, Paraskeva K, Papanikolaou IS, Triantafyllou K, Arvanitakis M, Archibugi L, Vanella G, Hollenbach M and Gkolfakis P. Endoscopic management of difficult biliary stones: an evergreen issue. Medicina (Kaunas) 2024; 60: 340.","journal-title":"Medicina (Kaunas)"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12893-019-0480-1","article-title":"Intrahepatic bile duct exploration lithotomy is a useful adjunctive hepatectomy method for bilateral primary hepatolithiasis: an eight-year experience at a single centre","volume":"19","author":"EL","year":"2019","unstructured":"Li EL, Yuan RF, Liao WJ, Feng Q, Lei J, Yin XB, Wu LQ and Shao JH. Intrahepatic bile duct exploration lithotomy is a useful adjunctive hepatectomy method for bilateral primary hepatolithiasis: an eight-year experience at a single centre. BMC Surg 2019; 19: 16.","journal-title":"BMC Surg"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"5158580","DOI":"10.1155\/2023\/5158580","article-title":"Surgical management of recurrence of primary intrahepatic bile duct stones","volume":"2023","author":"Xia","year":"2023","unstructured":"Xia H, Zhang H, Xin X, Liang B, Yang T, Liu Y, Wang J and Meng X. Surgical management of recurrence of primary intrahepatic bile duct stones. Can J Gastroenterol Hepatol 2023; 2023: 5158580.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/1871520618666180628155931","article-title":"Pharmacological effects and chemical constituents of bupleurum","volume":"19","author":"Sun","year":"2019","unstructured":"Sun P, Li Y, Wei S, Zhao T, Wang Y, Song C, Xue L, Wang F, Xiao L, Wu J and Qiao M. Pharmacological effects and chemical constituents of bupleurum. Mini Rev Med Chem 2019; 19: 34-55.","journal-title":"Mini Rev Med Chem"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3390\/nu15040808","article-title":"protects from acetaminophen-induced hepatotoxicity by regulating the Sirt1\/HO-1 signaling pathway","volume":"15","author":"Kim","year":"2023","unstructured":"Kim H, Hong J, Lee J, Jeon W, Yeo C, Lee Y, Baek S and Ha I. Curcuma aromatica Salisb. protects from acetaminophen-induced hepatotoxicity by regulating the Sirt1\/HO-1 signaling pathway. Nutrients 2023; 15: 808.","journal-title":"Nutrients"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/ptr.6054","article-title":"Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: review","volume":"32","author":"Soleimani","year":"2018","unstructured":"Soleimani V, Sahebkar A and Hosseinzadeh H. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: review. Phytother Res 2018; 32: 985-995.","journal-title":"Phytother Res"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"951521","DOI":"10.3389\/fphar.2022.951521","article-title":"Chrysophanol-8-O-glucoside protects mice against acute liver injury by inhibiting autophagy in hepatic stellate cells and inflammatory response in liver-resident macrophages","volume":"13","author":"Wang","year":"2022","unstructured":"Wang T, Lu Z, Qu XH, Xiong ZY, Wu YT, Luo Y, Zhang ZY, Han XJ and Xie CF. Chrysophanol-8-O-glucoside protects mice against acute liver injury by inhibiting autophagy in hepatic stellate cells and inflammatory response in liver-resident macrophages. Front Pharmacol 2022; 13: 951521.","journal-title":"Front Pharmacol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3390\/antiox10091387","article-title":"Lysimachiae herba inhibits inflammatory reactions and improves lipopolysaccharide\/D-Galactosamine-induced hepatic injury","volume":"10","author":"Jeong","year":"2021","unstructured":"Jeong YH, Kim TI, Oh YC and Ma JY. Lysimachiae herba inhibits inflammatory reactions and improves lipopolysaccharide\/D-Galactosamine-induced hepatic injury. Antioxidants (Basel) 2021; 10: 1387.","journal-title":"Antioxidants (Basel)"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1111\/jcmm.14262","article-title":"A functional interaction between Hippo-YAP signalling and SREBPs mediates hepatic steatosis in diabetic mice","volume":"23","author":"Shu","year":"2019","unstructured":"Shu Z, Gao Y, Zhang G, Zhou Y, Cao J, Wan D, Zhu X and Xiong W. A functional interaction between Hippo-YAP signalling and SREBPs mediates hepatic steatosis in diabetic mice. J Cell Mol Med 2019; 23: 3616-3628.","journal-title":"J Cell Mol Med"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1080\/15384101.2016.1207840","article-title":"The Hippo pathway, p53 and cholesterol","volume":"15","author":"Aylon","year":"2016","unstructured":"Aylon Y and Oren M. The Hippo pathway, p53 and cholesterol. Cell Cycle 2016; 15: 2248-2255.","journal-title":"Cell Cycle"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/11\/ajtr0159997.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:59:55Z","timestamp":1766023195000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/11\/ajtr0159997.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":51,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/vxhu6738","relation":{},"ISSN":["1943-8141"],"issn-type":[{"type":"electronic","value":"1943-8141"}],"subject":[],"published":{"date-parts":[[2024]]}}}